# Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma

> **NCT00267046** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 49 (actual)

## Conditions studied

- Sarcoma
- Oral Mucositis

## Interventions

- **DRUG:** Palifermin
- **DRUG:** Placebo
- **DRUG:** Adriamycin (Doxorubicin)
- **DRUG:** Ifosfamide
- **DRUG:** Vincristine
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00267046
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267046, "Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00267046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*